Obermatt
See Similar Stocks →

Bundamedik

JKT:BMHS · ID1000161201
Health Care Providers & ServicesSmall

360

12
Medium confidence — indicative
EV / EBIT16
Price / Owner Earnings84
Owner Earnings Yield1
Dividend Yield1
Price/Sales87
EV / Gross Profit86
Price/Book95
Return on Capital15
Cash Return on Capital14
Return on Equity12
EBIT Margin19
Gross Profitability47
Cash Conversion96
Accruals48
Owner Earnings Margin13
Sales growth8
Profit Growth8
Long-Term EPS Growth42
Reinvestment69
Price momentum24
Debt load26
Refinancing80
Debt Payback1
Liquidity10
Analyst ratings—
Expectations trend—
Market mood1
Value Creation8/20creating some value
  • Creates more value than its capital costs
  • Owner earnings growing
  • Owner earnings per share growing
  • Reinvests at strong returns
  • Solid earnings base

What this means

Bundamedik clears its cost of capital, but the record is mixed across the five tests. Real value creation, just not yet consistent.

Profile

CountryIndonesia
IndustryHealth Care Providers & Services
SizeSmall
TypePublic Company
ExchangeIDX
Employees486
Websitebmhs.co.id
ISINID1000161201
Last UpdateApr 2, 2026
Indices
IDX Composite (Indonesia)
Themes
Health DiagnosticsReproductive HealthFertilityCardiovascularWomen's HealthUrologyNeurologyOncologyDentistrySurgeryChild CareHealth Care

Description

PT Bundamedik Tbk (Bundamedik) operates as a comprehensive healthcare provider, primarily focusing on delivering medical services through various subsidiaries engaged in healthcare management and medical supply distribution. Established with the aim…

Analysis

Middle-of-the-road

PT Bundamedik Tbk sits in the middle of our grid: average quality, average price, no obvious signal in either direction.

Valuation data is not available for this company.

Growth is tepid; the safety picture is adequate. The company scores 8/20 on our value-creation score: creating some value. Analyst sentiment is cautious.

No flags apply to this company at this time: accounts, balance sheet, and cash quality all pass. A clean bill of health is meaningful, not just the absence of a warning. This analysis describes numbers; it is not investment advice.

360° rank · history

1007550250
4
2026

All-time high

7

Mar 2026

All-time low

4

Jun 2026

Average rank

6

across all years

Detailed & Historical Ranks

Deep dive into 15 detailed ranks and 3 years of history.

Current202520242023
Price/Sales
87
—
—
—
Price/Earnings
3
—
—
—
Price/Book
95
—
—
—
Dividend Yield
1
—
—
—
Value (overall)
50
—
—
—

Cells are coloured by rank band (red weak → green strong). Sentiment & 360° history begins 2023.

Similar Stocks

The companies this stock is ranked against.

Compare Bundamedik with its peers
IHH Healthcare
KLS:IHH
36
CountryMalaysia
IndustryHealth Care Providers & Services
SizeX-Large
Full Stock Analysis →
Sikarin
SET:SKR
57
CountryThailand
IndustryHealth Care Providers & Services
SizeSmall
Full Stock Analysis →
Patrangsit Healthcare
SET:PHG
85
CountryThailand
IndustryHealth Care Providers & Services
SizeSmall
Full Stock Analysis →
Max Healthcare Institute
NSI:MAXHEALTH
58
CountryIndia
IndustryHealth Care Providers & Services
SizeLarge
Full Stock Analysis →
Fortis Healthcare
NSI:FORTIS
71
CountryMalaysia
IndustryHealth Care Providers & Services
SizeLarge
Full Stock Analysis →
Mahachai Hospital
SET:M-CHAI
39
CountryThailand
IndustryHealth Care Providers & Services
SizeSmall
Full Stock Analysis →

Make Sense of the Ranks

Every rank runs 1–100 against true peers. Higher is always better.

360° View
1 · Watch OutGood· 100
Value
1 · ExpensiveGood Value· 100
Quality
1 · Weak FundamentalsHigh Quality· 100
Growth
1 · Tough TimesHigh Growth· 100
Safety
1 · High LeverageWell-Financed· 100
Sentiment
1 · SkepticismPositive· 100
Learn More →